Search - tctmd.com

Displaying 141 - 160 of 355

Sort: Relevancy | Date

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Jason Kahn

March 31, 2014

Presentation CIT 2014

XIENCE V China RCT 2 Year Results:A Prospective, Multi-center Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting Stent

Presenter: Gao Runlin

March 22, 2014

News Daily News

ZES Continue to Match EES in All Comers at 4 Years

March 13, 2014

News Daily News

Tras 4 Años, os SLZ siguen Equiparándose a los SLE en Ensayos de Pacientes No Seleccionados

March 13, 2014

News Daily News

4年数据显示ZES在所有方面均可媲美EES

March 13, 2014

News Industry News

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

March 10, 2014

News Daily News

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

January 22, 2014

News Daily News

RIBS V Publicado: Buenos Resultados con BLF y SLE en el Tratamiento de Pacientes con Reestenosis intra Stent del SMD

January 22, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

January 09, 2014

Presentation

Randomized Comparison of Xience V and Multi-link Stents in the Same Multivessel Patient with CKD

Presenter: Fabrizio Tomai

January 07, 2014

News Daily News

Los SLF de 1ª Generación son Menos Rentables que SMD + Rapamicina Oral a los 5 Años

January 06, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

January 01, 2014

News Industry News

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

November 24, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

Presenter: Yuejin Yang

October 29, 2013

Advertisement

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

XIENCE V China RCT 2 Year Results:A Prospective, Multi-center Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting Stent

ZES Continue to Match EES in All Comers at 4 Years

Tras 4 Años, os SLZ siguen Equiparándose a los SLE en Ensayos de Pacientes No Seleccionados

4年数据显示ZES在所有方面均可媲美EES

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

RIBS V Publicado: Buenos Resultados con BLF y SLE en el Tratamiento de Pacientes con Reestenosis intra Stent del SMD

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

Randomized Comparison of Xience V and Multi-link Stents in the Same Multivessel Patient with CKD

Los SLF de 1ª Generación son Menos Rentables que SMD + Rapamicina Oral a los 5 Años

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

Innovation in Intervention: Perspectives from Industry

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content